Treatment in

Blood And Marrow Transplant & Cellular Therapy

Schedule Appointment

A blood and marrow transplant replaces a person's abnormal stem cells with healthy ones from another person (a donor) and is most often used to treat patients with blood cancers or other blood disorders. This procedure allows the recipient to get new stem cells that work properly. We were the first institution to successfully complete a bone marrow transplant– back in 1968.

Overview

Three main types of blood and marrow transplant we perform include:

  • Autologous transplant
  • Allogeneic related donor transplant
  • Allogeneic unrelated donor transplant


Our blood and marrow transplant care teams also manage care for patients receiving CAR T-cell therapy, cellular therapies, and some forms of immunotherapy treatment.

Our approach

People travel from across the country and around the world for Blood and Marrow Transplant (BMT) treatment at our hospitals. University of Minnesota Medical Center and University of Minnesota Masonic Children's Hospital have provided compassionate, expert, innovative care to blood and marrow transplant (BMT) patients for more than 50 years.

Our program has been at the forefront of advances since performing the world's first successful BMT in 1968. Our teams have performed more than 8,000 BMTs since that time.

Driving research to reality
Our BMT Program continues to thrive as one of the most respected BMT research and treatment programs in the world. Here’s why:

  • We offer the highest-quality treatment and care based on your specific circumstances and needs.
  • Our first-rate researchers are committed to turning what they learn through research into successful treatment options.
  • We have the largest umbilical cord blood program in the country, making BMT a realistic option for more patients than ever before.
  • In 2005, our researchers were the first to report the success of using a unique type of donor cells for treatment of an advanced type of leukemia. They used Natural Killer (NK) cells to successfully treat advanced acute myelogenous leukemia (AML).
  • We offer you a patient- and-family-centered care approach to provide high-quality, compassionate care.
  • We continually strive to improve the safety and effectiveness of transplant therapy, to provide you and all our patients with the best possible outcomes.